A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapies
While there has been significant progress in advancing novel immune therapies to the bedside, much more needs to be done to fully tap into the potential of the immune system. It has become increasingly clear that besides practical and operational challenges, the heterogeneity of cancer and the limit...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551774/ |